Emergent Biosolutions (NYSE:EBS) reported Q2 2018 earnings this Afternoon, coming in at $1.07 per share, beating Wall Street’s estimates of $0.89 per Share. Revenue for the quarter came in at $220.20 million beating analyst estimates of $208.94 million
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.